155 related articles for article (PubMed ID: 37668669)
1. Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic.
Lincoln AG; Benton SC; Piggott C; Sheikh SR; Beggs AD; Buckley L; DeSouza B; East JE; Sanders P; Lim M; Sheehan D; Snape K; Hanson H; Greenaway JR; Burn J; Nylander D; Hawkins M; Lalloo F; Green K; Lee TJ; Walker J; Matthews G; Rutherford T; Sasieni P; Monahan KJ
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37668669
[TBL] [Abstract][Full Text] [Related]
2. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.
Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ
BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients.
D'Souza N; Hicks G; Benton SC; Abulafi M
Ann R Coll Surg Engl; 2020 Mar; 102(3):174-179. PubMed ID: 31697171
[TBL] [Abstract][Full Text] [Related]
4. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
[TBL] [Abstract][Full Text] [Related]
5. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
[TBL] [Abstract][Full Text] [Related]
6. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
7. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
8. The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referrals.
Kamel F; Zulfiqar S; Penfold W; Weatherell S; Madani R; Nisar P; Bearn P
Colorectal Dis; 2022 Jun; 24(6):727-736. PubMed ID: 35297169
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.
Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M
Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625
[TBL] [Abstract][Full Text] [Related]
10. Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study.
D'Souza N; Delisle TG; Chen M; Benton SC; Abulafi M;
Br J Surg; 2021 Jul; 108(7):804-810. PubMed ID: 33755051
[TBL] [Abstract][Full Text] [Related]
11. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
Maclean W; Limb C; Mackenzie P; Whyte MB; Benton SC; Rockall T; Jourdan I
Colorectal Dis; 2021 Jul; 23(7):1622-1629. PubMed ID: 33068489
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
13. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
[TBL] [Abstract][Full Text] [Related]
14. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.
Collins MG; Teo E; Cole SR; Chan CY; McDonald SP; Russ GR; Young GP; Bampton PA; Coates PT
BMJ; 2012 Jul; 345():e4657. PubMed ID: 22833618
[TBL] [Abstract][Full Text] [Related]
16. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
[TBL] [Abstract][Full Text] [Related]
17. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
[TBL] [Abstract][Full Text] [Related]
18. Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
Gerrard AD; Maeda Y; Miller J; Gunn F; Theodoratou E; Noble C; Porteous L; Glancy S; MacLean P; Pattenden R; Dunlop MG; Din FVN;
Br J Surg; 2023 Mar; 110(4):471-480. PubMed ID: 36785496
[TBL] [Abstract][Full Text] [Related]
19. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
[TBL] [Abstract][Full Text] [Related]
20. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]